Medical supplier Medline aims to raise over $5 billion in 2025 IPO, sources say
By Echo Wang
NEW YORK, Nov 21 (Reuters) -Private equity-owned Medline Industries is aiming to raise more than $5 billion in its U.S. initial public offering expected to happen in 2025, people familiar with the matter told Reuters on Thursday.
The stock market flotation could value Medline at about $50 billion and is expected to launch during the second quarter, the sources said, cautioning that the company's plans are subject to market conditions and could change.
Northfield, Illinois-based Medline, which is owned by buyout firms Blackstone BX.N, Carlyle CG.O, and Hellman & Friedman, has invited several investment banks to pitch for lead roles on what is likely to be one of the marquee IPOs next year, the sources said, requesting anonymity as the discussions are confidential.
Medline did not immediately respond to requests for comment. Blackstone, Carlyle, and Hellman & Friedman declined to comment.
Medline, which was acquired by its current private equity owners in a deal worth $34 billion in 2021, is one of the largest manufacturers and distributors of medical supplies such as surgical equipment, gloves, and laboratory devices used by hospitals around the world.
The company, which employs about 43,000 people worldwide and operates in more than 100 countries, currently generates annual sales of more than $23 billion, according to its website.
Bloomberg reported on Medline's IPO preparations in July.
Reporting by Echo Wang in New York; Editing by Anirban Sen and Bill Berkrot
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
